MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202511018981 A) filed by Council Of Scientific And Industrial Research An Indian on March 03, 2025, for Indazole Compounds Effective Against Drug Resistant Tuberculosis And Process For Preparation Thereof.
Inventors include Haridas Baburao Rode; Komal Govind Sangu; Shivani Prakash Maykalwar; and Vijayan Nynar Azger Dusthackeer.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: The fight against TB still continues despite chemotherapy and the directly observed treatment short-course (DOTS) approach to treat it. The development of resistance to the current therapy has thrown a big challenge as there are limited options available to treat the drug-resistant tuberculosis. In this direction, we have synthesized indazole containing thiazole and furan derivatives having nitro substituents. These derivatives showed activity against M. tuberculosis H37Rv. Importantly, these derivatives are highly effective against drug-resistant M. tuberculosis H37Rv clinical isolates.
Disclaimer: Curated by HT Syndication.
